579-93-1 | 2-(Benzoylamino)benzoic acid

Packsize	Purity	Availability	Price	Discounted Price
250mg	95%	in stock	$22.00	$15.00
1g	95%	in stock	$29.00	$20.00
5g	95%	in stock	$92.00	$64.00
10g	95%	in stock	$171.00	$120.00
25g	95%	in stock	$289.00	$202.00

Description

• Catalog Number: AG73565
• Chemical Name: 2-(Benzoylamino)benzoic acid
• CAS Number: 579-93-1
• Molecular Formula: C14H11NO3
• Molecular Weight: 241.242
• MDL Number: MFCD00444173
• SMILES: O=C(c1ccccc1)Nc1ccccc1C(=O)O
• NSC Number: 3866

Computed Properties

• Complexity: 310
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 18
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 3
• XLogP3: 3.5

Literature

• N-Benzoyl anthranilic acid derivatives as selective inhibitors of aldo-keto reductase AKR1C3.

  Bioorganic & medicinal chemistry letters 20120915

• Anthranilic acid-based inhibitors of phosphodiesterase: design, synthesis, and bioactive evaluation.

  Organic & biomolecular chemistry 20111021

• Inhibitors of the salicylate synthase (MbtI) from Mycobacterium tuberculosis discovered by high-throughput screening.

  ChemMedChem 20101203

• DSM-RX78, a new phosphodiesterase inhibitor, suppresses superoxide anion production in activated human neutrophils and attenuates hemorrhagic shock-induced lung injury in rats.

  Biochemical pharmacology 20091015

• Disubstituted 4(3H) quinazolones: a novel class of antitumor agents.

  Chemical biology & drug design 20090901

• In silico screening for PTPN22 inhibitors: active hits from an inactive phosphatase conformation.

  ChemMedChem 20090301

• Synthesis and anti-platelet evaluation of 2-benzoylaminobenzoate analogs.

  Bioorganic & medicinal chemistry 20080515

• QSAR studies on benzoylaminobenzoic acid derivatives as inhibitors of beta-ketoacyl-acyl carrier protein synthase III.

  European journal of medicinal chemistry 20080501

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of anticancer agents.

  Bioorganic & medicinal chemistry letters 20051201

• Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents.

  Journal of medicinal chemistry 20050310

• NMR-driven discovery of benzoylanthranilic acid inhibitors of far upstream element binding protein binding to the human oncogene c-myc promoter.

  Journal of medicinal chemistry 20040923